FULL-TEXT ARTICLE
Estimated hepatitis C prevalence and key population sizes in San Francisco:
A foundation for elimination.
Facente SN, Grebe E, Burk K, et al
PLoS One. 2018 Apr
11;13(4):e0195575.
Paper
Population level outcomes and cost-effectiveness of expanding the
recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Y
Clin Infect Dis. 2018
Feb 6.
Abstract
Increases in Acute Hepatitis C Virus Infection Related to a
Growing Opioid Epidemic and Associated
Injection Drug Use, United States, 2004 to 2014.
Zibbell JE, Asher AK, Patel RC, et al
Am J Public Health. 2018
Feb;108(2):175-181.
Abstract
Population level outcomes and cost-effectiveness of expanding the
recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Yazdi G, . et al
Clin Infect Dis. 2018
Feb
Abstract
Population level outcomes and cost-effectiveness of expanding the
recommendation for age-based hepatitis C testing in the United States.
Barocas JA, Tasillo A, Eftekhari Yazdi G,
Clin Infect Dis. 2018
Feb 6
Abstract
Increases in Acute Hepatitis C Virus Infection Related to a
Growing Opioid Epidemic and Associated Injection Drug Use, United States,
2004 to 2014.
Zibbell JE, Asher AK, Patel RC,
et
al
Am J Public Health.
2018 Feb;108(2):
Abstract
FULL-TEXT ARTICLE
Low hepatitis C antibody screening rates among an insured population
of Tennessean Baby Boomers.
Carlucci JG, Farooq SA, Sizemore L, et
al
PLoS One. 2017
Nov 30;12(11):e0188624.
Paper
Towards the Elimination of Hepatitis C in the United States.
Saab S, Le L, Saggi S, Sundaram V, Tong M
Hepatology. 2017 Nov 2
Abstract
Improving patient access to hepatitis C virus treatment.
McLaughlin MM, Marx KT, et alJ
Am Pharm Assoc (2003).
2017 Nov 16.
Abstract
FULL-TEXT ARTICLE
Local specialty pharmacy and specialty clinic collaboration assists access
to hepatitis C direct-acting antivirals.
Zhu J, Hazen
RJ, Joyce C, Delpino A
J Am Pharm Assoc (2003). 2017 Nov 16
Paper
Expansion of Treatment for Hepatitis C Virus Infection by
Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized
Clinical Trial.
Kattakuzhy S, Gross C, Emmanuel B,
et al
Ann Intern Med.
2017 Aug 8.
Abstract
Scaling up HCV prevention and treatment interventions
in rural USA - model projections for tackling an increasing epidemic.
Fraser H, Zibbell J, Hoerger T,
et al
Addiction. 2017 Jul
22.
Abstract
Silence Surrounding Hepatitis C Status in Risk Relationships
Among Rural People Who Use Drugs.
Hofmeister MG,
Havens JR, Young AM.
J Prim Prev. 2017 Jul 21.
Abstract
In an Era of Highly Effective Treatment, Hepatitis C Screening of the General
Population of the United States for Hepatitis C Should be Considered.
Younossi Z, Blissett D, Blissett R, et al
Liver Int. 2017 Jul
18.
Abstract
Racial Disparities in Hepatitis C Treatment Eligibility.
Sims OT, Pollio DE, Hong BA, North CS.
Ann Hepatol.
2017 Aug 1;16(4):530-537.
Abstract
Evaluating a Collaborative Approach to Improve Prior Authorization
Efficiency in the Treatment of Hepatitis C Virus.
Dunn EE, Vranek K, Hynicka LM,
Qual Manag Health Care.
2017 Jul/Sep;26(3):136
Abstract
State HCV Incidence and Policies Related to HCV Preventive
and Treatment Services For Persons Who Inject Drugs - United States,
2015-2016.
Campbell CA, Canary L, Smith N, et al
Am J Transplant. 2017 Jul;17(7):1945-1948.
Abstract
Hepatitis C Virus Prevalence in Egyptian Americans in
Southern California.
Saab S,
Viramontes MR, Chalifoux SL,
J Clin Gastroenterol.
2017 Jun 14
Abstract
Incidence
of Hepatitis C Virus Infection in the Human Immunodeficiency Virus
Outpatient Study Cohort, 2000-2013.
Samandari T, Tedaldi E, Armon C,
et al
Open Forum Infect Dis.
2017 Jun 10;4(2):ofx076.
Abstract
Value of Comprehensive HCV Treatment among Vulnerable,
High-Risk Populations.
Moreno GA, Wang A,
Sánchez González Y, et al
Value Health. 2017
Jun;20(6):736-744.
Abstract
Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and
Northern China.
Wu E, Yang M, Rao H, et al
Dig Dis Sci. 2017 Jun 1.
Abstract
FULL-TEXT ARTICLE
Virology analysis in HCV genotype 1-infected patients treated with the
combination of simeprevir and TMC647055/ritonavir, with and without
ribavirin, and JNJ-56914845
Vijgen L, Thys K, Vandebosch A,et al
Virol J. 2017 May
31;14(1):101
Paper
FULL-TEXT ARTICLE
Identifying
and characterizing hepatitis C virus hotspots in Massachusetts: a spatial
epidemiological approach.
Stopka
TJ, Goulart MA, Meyers DJ, et
al
BMC Infect Dis.
2017 Apr 20;17
Paper
Estimation of State-Level Prevalence of Hepatitis
C Virus Infection, US States and District of Columbia, 2010.
Rosenberg ES, Hall EW, Sullivan PS, et al
Clin Infect Dis.
2017 Apr 26.
Abstract
Combination of sofosbuvir, pegylated-interferon and ribavirin
for treatment of hepatitis C virus genotype 1 infection: a
systematic review and meta-analysis.
Dolatimehr F, Karimi-Sari H,
Rezaee-Zavareh MS,
et al
Daru.
2017 Apr 20;25(1):11
Abstract
Disease Burden, Early
Discontinuation, and Healthcare Costs in Hepatitis C Patients
with and without Chronic Kidney Disease Treated with
Interferon-Free Direct-Acting Antiviral Regimens.
Puenpatom A, Hull M, McPheeters J, Schwebke K.
Clin Drug Investig.
2017 Apr 6.
Abstract
Barriers to Hepatitis C Screening in a Minority
Population: A Comparison of Hepatitis C and Human
Immunodeficiency Virus Screening Rates at a Community STD Clinic
in Miami, Florida.
Feldman EB, Balise R, Schiff E, et al
J Community Health.
2017 Mar 28
Abstract
Improving Support and Education of Low Income
Baby Boomers Diagnosed with Chronic Hepatitis C Virus Infection
through Universal Screening.
Turner BJ, Craig K, Makanji VS,
et al
J Clin Nurs.
2017 Mar 15.
Abstract
Transformation of hepatitis C antiviral treatment in a national
healthcare system following the introduction of direct antiviral
agents.
Moon AM,
Green PK, Berry K, Ioannou GN.
Aliment
Pharmacol Ther.
2017 Mar 8.
Abstract
Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug
Interactions
Chan J,
Chung RT.
Clin
Pharmacol Drug Dev.
2017 Mar;6(2):147-163.
Abstract
Check Hep C: A Community-Based Approach to Hepatitis C Diagnosis
and Linkage to Care in High-Risk Populations.
Ford MM, Johnson N, Rude E,
et al
J Public Health Manag Pract.
2017 Jan 30.
Abstract
Changes in the Prevalence of Hepatitis C Virus Infection,
Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among
Patients with Cirrhosis or Liver Failure on the Waitlist for
Liver Transplantation.
Goldberg D, Ditah IC, Saeian K, et al
Gastroenterology. 2017
Jan 11.
Abstract
Treatment
and characteristics of patients treated for hepatocellular
carcinoma (HCC) by physician types in the United States.
Seal BS, Foltz Boklage SH, Asche CV.
J Clin Oncol. 2012
Feb;30(4_suppl):375.
Abstract
HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis
C Virus Have Less Hepatic Steatosis than Adults with Neither
Infection.
Price JC, Ma Y, Scherzer R, Korn N,
et al
Hepatology.
2016 Dec 16.
Abstract
FULL-TEXT ARTICLE
National Progress Toward Hepatitis C Elimination - Georgia,
2015-2016.
Gvinjilia L, Nasrullah M, Sergeenko D, et al
MMWR Morb Mortal Wkly Rep. 2016 Oct
21;65(41):1132-1135.
Paper
Pharmacist engagement within a
hepatitis C ambulatory care clinic in the era of a treatment
revolution.
Gauthier TP, Moreira E, Chan C,
et al
J Am Pharm Assoc (2003).
2016 Sep 22.
Abstract
Patient satisfaction with the clinical pharmacist and
prescribers during hepatitis C virus management.
Martin MT, Faber DM.
J Clin Pharm Ther.
2016 Aug 31.
Abstract
Assessing the Effect of Potential Reductions in Non-Hepatic
Mortality on the Estimated Cost-Effectiveness of Hepatitis C
Treatment in Early Stages of Liver Disease.
Leidner
AJ, Chesson HW, Spradling PR, Holmberg SD.
Appl Health Econ Health Policy.
2016 Aug 1
Abstract
FULL-TEXT ARTICLE
Increased Hepatitis C Virus (HCV) Detection in Women of
Childbearing Age and Potential Risk for Vertical Transmission -
United States and Kentucky, 2011-2014.
Koneru A, Nelson N, Hariri S, Canary L, et al
MMWR Morb Mortal Wkly Rep.
2016 Jul 22;65(28):705-10.
Paper
Access to New Medications for Hepatitis C for Medicaid
Members: A Retrospective Cohort Study.
Clements KM, Clark RE, Lavitas P, et al
J Manag Care Spec Pharm.
2016 Jun;22(6):714-722b.
Abstract
FULL-TEXT ARTICLE
Costs and spillover effects of private insurers' coverage of
hepatitis C treatment.
Moreno GA, Mulligan K, Huber C, et al
Am J Manag Care.
2016 May;22(6
Paper
HIV and Hepatitis C Virus Screening Practices in
a Geographically Diverse Sample of American Community Health
Centers.
Mayer KH, Crawford P, Dant L,
et
al
AIDS Patient Care STDS.
2016 Jun;30(6):237-246.
Abstract
Access to New Medications for Hepatitis C for
Medicaid Members: A Retrospective Cohort Study.
Clements KM, Clark RE, Lavitas
P, et al
J Manag Care Spec Pharm.
2016 Jun;22(6):714-722b.
Abstract
Long-term outcomes of lung transplant recipients with hepatitis C infection:
a retrospective study of the U.S. transplant registry.
Koenig A, Stepanova M, Saab S,
et al
Aliment
Pharmacol Ther. 2016
Jun 9
Abstract
Efforts at the Frontlines: Implementing a Hepatitis C Testing
and Linkage-to-Care Program at the Local Public Health Level
Seña AC, Willis SJ, Hilton A,
et
al
Public Health Rep.
2016 May-Jun;131 Suppl 2:57-64.
Abstract
FULL-TEXT ARTICLE
Coverage for hepatitis C drugs in Medicare Part D.
Jung JK, Feldman R, Cheong C, .
et al
Am J Manag Care.
2016 May;22(6 Spec No.):SP220-6.
Paper
FULL-TEXT ARTICLE
Linkage to Care for Suburban Heroin Users with Hepatitis C Virus
Infection, New Jersey, USA.
Akyar E, Seneca KH, Akyar S, et al
Emerg Infect Dis.
2016 May;22(5):907-9.
Paper
Higher all-cause hospitalization among patients with chronic
hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS),
2006-2013.
Teshale EH, Xing J, Moorman A,
et
al
J Viral Hepat.
2016 May 15
Abstract
Cost-Effectiveness of the Hepatitis C
Self-Management Program.
Groessl EJ, Sklar M, Laurent DD, et al
Health Educ Behav.
2016 May 19
Abstract
FULL-TEXT ARTICLE
Identification and Clinical Management of Persons with Chronic
Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
Mera J, Vellozzi C, Hariri S,
et
al
MMWR Morb Mortal
Wkly Rep.
2016 May 13;65(18):461-6.
Paper
Association of Hepatitis C Virus With Alcohol Use Among U.S.
Adults: NHANES 2003-2010.
Taylor AL, Denniston MM, Klevens RM,
Am J Prev Med. 2016 May
Abstract
Hepatitis C Virus Genotype and Subtype Distribution in Patient
Specimens Tested at the University of Texas Medical Branch,
Galveston, Between January 2011 and November 2014.
Xie Y, Garza G, Dong J.
Lab Med.
2016 May;47(2):112-118.
Abstract
Efforts at the Frontlines: Implementing a Hepatitis C Testing
and Linkage-to-Care Program at the Local Public Health Level.
Seña
AC, Willis SJ, Hilton A, et al
Public Health Rep.
2016 May-Jun;131(Suppl 2):57-64.
Abstract
Integrating Routine HCV Testing in Primary Care:
Lessons Learned from Five Federally Qualified Health Centers in
Philadelphia, Pennsylvania, 2012-2014.
Coyle C, Kwakwa H, Viner K.
Public Health Rep.
2016 May-Jun;131(Suppl 2):65-73
Abstract
Improved Survival Among all Interferon-α-Treated Patients in
HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients,
Despite Increased Cirrhosis Among Nonresponders.
Cozen ML, Ryan JC, Shen H, et al
Dig Dis Sci.
2016 Apr 8.
Abstract
FULl-TEXT
ARTICLE
Implementation of baby boomer hepatitis C screening and linking
to care in gastroenterology practices: a multi-center pilot
study.
Younossi
ZM, LaLuna LL, Santoro JJ,
et al
BMC Gastroenterol.
2016 Apr 4;16(1):45
Paper
FULL-TEXT ARTICLE
Hepatitis C testing in substance use disorder treatment: the
role of program managers in adoption of testing services.
Frimpong JA, D'Aunno T.
Subst Abuse Treat Prev Policy.
2016 Apr 1;11(1):13..
Paper
High-impact hepatitis C virus testing for injection drug users
in an urban ED.
Anderson ES, Pfeil SK, Deering LJ,
et al
Am J Emerg Med.
2016 Mar 3.
Abstract
Presence of hepatitis C (HCV) infection in Baby Boomers with
Medicare is independently associated with mortality and resource
utilisation.
Sayiner M, Wymer M, Golabi P, et al
Aliment Pharmacol Ther.
2016 Mar 15.
Abstract
An assessment of concurrent drug and alcohol use among patients
seeking treatment for hepatitis C
Sims OT, Pollio DE, Hong BA, et al
Ann Clin Psychiatry.
2016 Feb;28(1):31-6.
Abstract
A Systematic Review of Race and Ethnicity in Hepatitis C
Clinical Trial Enrollment.
Wilder J, Saraswathula A, Hasselblad V, Muir A.
J Natl Med Assoc.
2016 Feb;108(1):24-29
Abstract
Public health clinic-based hepatitis C testing and linkage to
care in Baltimore.
Falade-Nwulia O, Mehta SH, Lasola J,
et al
J Viral
Hepat. 2016 Feb 3.
Abstract
Disparate access to treatment regimens in chronic hepatitis C
patients: data from the TRIO network.
Younossi ZM, Bacon BR, Dieterich DT,
et al
J Viral Hepat.
2016 Feb 3.
Abstract
Strengthening Screening for HIV, Hepatitis C, and STIs: An Innovative
Partnership Between the Health Department and Community Health Centers in
New York City.
Terranova E, Tsoi B, Laraque F, Washburn K, Fuld
J.
Public Health Rep. 2016 Jan-Feb;131 Suppl 1:5-10.
Abstract
Increasing Prevalence of Cirrhosis among
US Adults Aware or Unaware of their Chronic Hepatitis C Virus
Infection.
Udompap P, Mannalithara A, Heo N, et al
J Hepatol. 2016 Jan 22.
Abstract
HCV Prevalence in Asian Americans in California.
Lin ON, Chang C, Lee J, et al
J Immigr Minor Health.
2016 Jan 21
Abstract
Treating Hepatitis C in a Ryan White-Funded HIV
Clinic: Has the Treatment Uptake Improved in the Interferon-Free
Directly Active Antiviral Era?
Cope R, Glowa T,
Faulds S, et al
AIDS Patient Care STDS.
2016 Jan 8.
Abstract
Hepatitis C Virus Infection Screening Within Community Health
Centers.
Cook N,
Turse EP, Garcia AS,
et
al
J Am Osteopath Assoc.
2016 Jan 1;116(1):6-11.
Abstract
FULL-TEXT ARTICLE
Notes from the Field: Hepatitis C Outbreak in a Dialysis Clinic
- Tennessee, 2014.
Muleta D, Kainer MA, Moore-Moravian L,
et al
MMWR Morb Mortal Wkly Rep. 2016
Jan 1;64(50-51):1386-7
Paper
The burden of hepatitis C to the United States Medicare system in 2009:
Descriptive and economic characteristics.
Rein DB, Borton J, Liffmann DK, Wittenborn JS.
Hepatology. 2015 Dec 28.
Abstract
An evaluation of hepatitis C knowledge and
correlations with health belief model constructs among African
American "baby boomers".
Rashrash ME, Maneno MK, Wutoh AK, et al
J Infect Public Health. 2015 Dec 16.
Abstract
The Impact of Enhanced Screening and Treatment on Hepatitis C in the United
States.
Durham DP, Skrip LA, Bruce RD,
et al;
Clin Infect Dis.
2015 Nov 30.
Abstract
High adherence to all-oral directly acting antiviral HCV therapy
among an inner-city patient population in a phase 2a study.
Petersen T, Townsend K, Gordon LA, et al
Hepatol Int. 2015 Nov
26
Abstract
Emergency Department Screening for Hepatitis C Virus: Geographic Reach and
Spatial Clustering in Central Alabama.
Donnelly JP, Franco R, Wang HE, Galbraith JW.
Clin Infect Dis. 2015 Nov 26.
pii: civ984.
Abstract
FULL-TEXT ARTICLE
Simple,
Effective, but Out of Reach? Public Health Implications of HCV Drugs.
Ward JW, Mermin JH.
N Engl J Med. 2015 Nov 17.
Paper
Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an
opportunity to decrease transmission.
Young KL, Huang W, Horsburgh CR,
et al
J Viral Hepat. 2015 Nov 17.
Abstract
Factors Associated with Hepatitis C Knowledge Before and After an
Educational Intervention among Vietnamese Americans.
Lee S, Zhai S, Zhang GY,
Clin Med Insights Gastroenterol.
2015 Oct 29;8:45-53.
Abstract
Show Me Echo - Hepatitis C: A telemedicine mentoring program for patients
with hepatitis C in underserved and rural areas in Missouri as a model in
developing countries.
Tahan V, Almashhrawi A, Mutrux R, Ibdah JA.
Turk J Gastroenterol. 2015
Oct 26.
Abstract
Costs and consequences: Hepatitis C seroprevalance in the military and its
impact on potential screening strategies.
Brett-Major DM, Frick KD, Malia JA, et al
Hepatology. 2015 Oct
20.
Abstract
Task-Shifting: An Approach to Decentralized Hepatitis C Treatment
in Medically Underserved Areas.
Jayasekera CR,
Perumpail RB, Chao DT,
et al
Dig Dis Sci. 2015 Oct 14
Abstract
FULL-TEXT ARTICLE
New all oral therapy for chronic hepatitis C virus (HCV): a
novel long-term cost comparison.
Poonsapaya JM,
Einodshofer M, Kirkham HS, et al
Cost Eff Resour Alloc.
2015 Oct 6;13:17.
Paper
Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in
Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol.
Redulla RR, Reddy KR, Faust TW, Dudley-Brown S
Gastroenterol Nurs.
2015 Sep-Oct;38(5):369-78
Abstract
Hepatitis C Infection Among Hispanics in California.
Cummins CA, Erlyana E, Fisher DG, Reynolds GL.
J Addict Dis. 2015 Sep 15:
Abstract
Hepatitis C Virus in the US Military Retiree Population: To
Screen, or Not to Screen?
Laufer CB, Carroll MB.
J Clin Med Res. 2015 Oct;7(10):757-61.
Abstract
The cost-effectiveness of novel direct acting antiviral agent
therapies for the treatment of chronic hepatitis C.
Bickerstaff C.
Expert Rev Pharmacoecon Outcomes Res. 2015 Aug
10:1-14
Abstract
Access to Costly New Hepatitis C Drugs: Medicine, Money and Advocacy.
Trooskin SB, Reynolds H, Kostman JR.
Clin Infect Dis. 2015 Aug 12.
Abstract
Dialysis-requiring acute kidney injury among hospitalized adults
with documented hepatitis C Virus infection: a nationwide inpatient sample
analysis.
Nadkarni GN, Patel A, Simoes PK, et al
J Viral Hepat. 2015 Jul 20.
Abstract
Health Beliefs and Co-morbidities Associated with Appointment-Keeping Behavior
Among HCV and HIV/HCV Patients.
Pundhir P, North CS, Fatunde O, Jain MK.
J Community Health. 2015 Jul 16.
Abstract
Towards a more accurate estimate of the prevalence of hepatitis C
in the United States.
Edlin BR, Eckhardt BJ,
Shu MA, et al
Hepatology. 2015 Jul 14.
Abstract
Underascertainment of Acute Hepatitis C Virus Infections in
the U.S. Surveillance System: A Case Series and Chart Review.
Onofrey S, Aneja J, Haney GA, Nagami EH,
et al
Ann
Intern Med. 2015 Jun 30.
Abstract
The common sense model applied to hepatitis C: a qualitative
analysis of the impact of disease comparison and witnessed death on
hepatitis C illness perception.
Safo SA, Batchelder
A, Peyser D, Litwin A.
Harm Reduct
J. 2015 Jun
20;12(1):20.
Abstract
"Hepatitis C treatment turned me around:" Psychological
and behavioral transformation related to hepatitis C treatment.
Batchelder AW, Peyser D, Nahvi S, et akl
Drug Alcohol Depend. 2015 Jun 9.
Abstract
Hepatitis C virus in Mexican Americans: a population-based
study reveals relatively high prevalence and negative association with
diabetes.
Watt GP, Vatcheva
KP, Beretta Let al,
Epidemiol Infect.
2015 Jun 19:
Abstract
Costs and absence of HCV-infected employees by disease stage.
Baran RW, Samp JC, Walker DR,
et al
J Med Econ. 2015 Jun 5:1-13|
Abstract
Implementing hospital-based baby boomer hepatitis c virus
screening and linkage to care: Strategies, results, and costs.
Turner BJ, Taylor BS, Hanson JT, et al
J Hosp Med. 2015 May 29.
Abstract
Update on Hepatitis C: epidemiology, treatment and resistance to
antiviral therapies.
Ness E, Kowdley KV.
Minerva Gastroenterol Dietol.
2015 May 20.
Abstract
Effect of Gender on the Response to Hepatitis C Treatment in
an Inner-City Population.
Simoes P, Asaad A, Abed
J, et al
Womens Health Issues. 2015
May-Jun;25(3):289-293.
Abstract
FULL-TEXT
ARTICLE
Identification
and Linkage to Care of HCV-Infected Persons in Five Health Centers -
Philadelphia, Pennsylvania, 2012-2014.
Coyle C, Viner K, Hughes E,
et
al
MMWR Morb Mortal Wkly Rep.
2015 May 8;64(17):459-463.
Paper
Transmission of Hepatitis C Virus From Organ Donors Despite
Nucleic Acid Test Screening.
Suryaprasad A, Basavaraju SV, Hocevar SN, et al
Am J Transplant. 2015 May 5
Abstract
Implementing Updated Recommendations on Hepatitis C Virus
Screening: Translating Federal Guidance Into State Practice.
Martin EG, Norcott AM,
Khalid H, OʼConnell DA.
J Public Health Manag Pract. 2015 Apr 22
Abstract
Increase in nonhepatic diagnoses among persons with hepatitis C
hospitalized for any cause, United States, 2004-2011.
Tong X, Spradling PR.
J Viral
Hepat. 2015 Apr 20.
Abstract
FULL-TEXT
ARTICLE
Spatiotemporal Analysis of Hepatitis C Virus Infection.
Shulla A, Randall G.
PLoS Pathog.
2015 Mar 30;11(3):e1004758
Paper
Bacteremia in hemodialysis patients with hepatitis C.
Chebrolu P, Colombo RE, Baer S,
et al
Am J Med Sci. 2015 Mar;349(3):217-21
Abstract
Lack of Health Insurance Limits the Benefits of Hepatitis C Virus
Screening: Insights from the National Health and Nutrition Examination Hepatitis
C Follow-Up Study.
Ditah I, Al Bawardy B, Gonzalez HC, et al
Am J Gastroenterol.
2015 Mar 10.
Abstract
Contextual analysis of
determinants of late diagnosis of hepatitis C virus infection in Medicare
patients.
Chirikov VV, Shaya FT, Howell CD.
Hepatology. 2015 Mar
7.
Abstract
FULL-TEXT ARTICLE
Transmission
of hepatitis C virus associated with surgical procedures - New Jersey 2010
and Wisconsin 2011.
Apostolou A, Bartholomew ML,
Greeley R et al
MMWR Morb Mortal Wkly Rep. 2015 Feb
27;64(7):165-70.
Paper
Results from a Geographically Focused, Community-Based
HCV Screening, Linkage-to-Care and Patient Navigation Program.
Trooskin SB, Poceta J, Towey CM, et al.
J Gen Intern Med.
2015 Feb
Abstract
Cost-effectiveness of hepatitis C treatment for patients in
early stages of liver disease.
Leidner AJ, Chesson HW, Xu F, et al
Hepatology. 2015 Feb 11
Abstract
"Test, Listen, Cure" (TLC) Hepatitis C Community Awareness
Campaign.
Coughlin SS.
JMIR Res Protoc. 2015 Feb
6;4(1):e13.
Abstract
Reasons for HCV non-treatment in underserved African
Americans: Implications for treatment with new therapeutics.
Schaeffer S, Khalili M.
Ann
Hepatol.
2015 Mar-Apr 2015;14(2):234-2
Abstract
A Window of Opportunity: Maximizing the Effectiveness of New HCV
Regimens in the United States With the Expansion of the Affordable Care Act.
Haley SJ, Kreek MJ.
Am J Public Health. 2015 Jan
20:e1-e7
Abstract
Hepatitis C Virus Antibody Prevalence, Demographics and
Associated Factors among Persons Screened at Hawai'i Community-based Health
Settings, 2010-2013.
Takeuchi LC, Pham TK,
Katz AR.
Hawaii J Med Public Health. 2015
Jan;74(1):9-15.
Abstract
FULL=TEXT ARTICLE
HIV and Hepatitis C Mortality in Massachusetts, 2002-2011: Spatial Cluster
and Trend Analysis of HIV and HCV Using Multiple Cause of Death.
Meyers DJ, Hood ME, Stopka TJ.
PLoS One.
2014 Dec 11;9(12):e114822.
Paper
Provider Workforce Assessment in a Rural Hepatitis C
Epidemic: Implications for Scale-up of Antiviral Therapy.
Westergaard RP, Stockman LJ,
Hyland HA, et al
J Prim Care Community Health.
2014 Nov 24
Abstract
Utility of Evaluating HCV in an Uninsured Population.
Donepudi I, Paredes
A, Hubbard S, et al
Dig Dis Sci. 2014 Nov 5
Abstract
Changes in characteristics of hepatitis C patients seen in a
liver centre in the United States during the last decade.
Talaat N, Yapali S, Fontana RJ, et al
J Viral Hepat. 2014 Oct 14.
Abstract
Risk for Hepatitis B and C Virus Transmission in Nail Salons and Barbershops and
State Regulatory Requirements to Prevent Such Transmission in the United States.
Yang J, Hall K, Nuriddin A, Woolard D.
J Public Health Manag Pract.
2014 November/December;20(6):E20-E30
Abstract
Age Cohort Differences in Illicit Drug Use and HCV among African
American Substance Users.
Whitehead NE, Hearn L, Trenz RC, et al
J Addict Dis. 2014 Oct 9:0.
Abstract
Hospitalizations and costs associated with hepatitis C and advanced liver
disease continue to increase.
Xu F, Tong X, Leidner AJ.
Health Aff (Millwood). 2014 Oct 1;33(10):1728-35.
Abstract
Impact of Completing Chronic Hepatitis C (CHC) Treatment on
Post-Therapy Healthcare Cost.
Tandon N, Balart L, Laliberté F, et al
J Med Econ. 2014 Sep 12:1-26.
Abstract
Current Practices of Screening for Incident Hepatitis C Virus
Infection among HIV- Infected, HCV-Uninfected Individuals in Primary Care.
Freiman JM, Huang W, White L, et al
Clin Infect Dis.
2014 Sep 3.
Abstract
Hepatitis C in African Americans.
Saab S, Jackson C,
Nieto DO et al
Am J Gastroenterol. 2014 Sep 2.
Abstract
Unrecognized chronic hepatitis C virus infection among baby
boomers in the emergency department.
Galbraith JW, Franco RA, Donnelly
JP, et al
Hepatology. 2014 Sep 1
Abstract
Follow-up testing for hepatitis C virus infection: an analysis of
Massachusetts surveillance data, 2007-2010.
Barton K, Church D, Onofrey S, Cocoros N, DeMaria A Jr
Public Health Rep.
2014 Sep;129(5):403-7.
Abstract
Comparison of hepatitis C virus testing strategies: birth
cohort versus elevated alanine aminotransferase levels.
Smith BD, Yartel AK.
Am J Prev Med. 2014
Sep;47(3):233-41.
Abstract
Ending hepatitis C in the United States: the role of screening.
Coffin PO, Reynolds A.
Hepat Med.
2014 Jul 3;6:79-87.
Abstract
Impact of Race/Ethnicity and Gender on HCV Screening and
Prevalence Among US Veterans in Department of Veterans Affairs Care.
Backus LI, Belperio PS,
Loomis TP, Mole LA.
Am J Public Health.
2014 Sep;104 Suppl
4:S555-61.
Abstract
The changing burden of hepatitis C virus infection in the
United States: model-based predictions.
Kabiri M, Jazwinski AB,
Roberts MS, et al
Ann Intern Med. 2014 Aug
5;161(3):170-80.
Abstract
Medication use and medical comorbidity in patients with
chronic hepatitis C from a US commercial claims database: high utilization
of drugs with interaction potential.
Lauffenburger JC,
Mayer CL, Hawke RL, et al
Eur J Gastroenterol Hepatol.
2014 Jul 10.
Abstract
Trends in HCV RNA testing among HCV antibody positive persons
in care, 2003-2010.
Spradling PR, Tong
X, Rupp L, et al
Clin Infect Dis. 2014 Jul 2
Abstract
Estimating the true prevalence of hepatitis C in Rhode Island.
Kinnard EN, Taylor LE, Galárraga O, Marshall BD.
R I Med J (2013).
2014 Jul 1;96(7):19-24
Abstract
HCV among The Miriam Hospital and Rhode Island Hospital Adult ED
Patients.
Merchant RC, Baird JR, Liu T, Taylor LE.
R I Med J (2013). 2014 Jul
1;96(7):35-9.
Abstract
Substance use and hepatitis C: An ecological momentary assessment
study.
Phillips KA, Epstein DH, Vahabzadeh M, et al
Health Psychol. 2014
Jul;33(7):710-9.
Abstract
FULL TEXT ARTICLE
Higher risk of
incident hepatitis C virus among young women who inject drugs compared with
young men in association with sexual relationships: a prospective analysis
from the UFO Study cohort.
Tracy D, Hahn JA, Fuller Lewis C, et al
BMJ Open.
2014 May 29;4(5):e004988
Paper
Inpatient resource utilization, disease severity, mortality
and insurance coverage for patients hospitalized for hepatitis C virus in
the United States.
Younossi ZM, Otgonsuren M,
Henry L,
et al
J Viral Hepat. 2014 May
12.
Abstract
FULL-TEXT
ARTICLE
Expanding primary care capacity to treat hepatitis C virus infection through
an evidence-based care model - Arizona and Utah, 2012-2014.
Mitruka K, Thornton K, Cusick S, et al
MMWR Morb Mortal Wkly Rep.
2014 May 9;63(18):393-8.
Paper
Hepatitis B Virus and Hepatitis C Virus Infections in United
States-Bound Refugees from Asia and Africa.
Mixson-Hayden T, Lee D, Ganova-Raeva L
Am J Trop Med Hyg. 2014
Apr 14.
Abstract
FULL-TEXT ARTICLE
Rapid
hepatitis C testing among persons at increased risk for infection -
Wisconsin, 2012-2013.
Stockman LJ, Guilfoye SM, Benoit AL,
MMWR Morb Mortal Wkly Rep.
2014 Apr 11;63(14):309-11.
Paper
Racial Disparities in the Proportion of Current, Unresolved
Hepatitis C Virus Infections in the United States, 2003-2010.
Liu G, Holmberg SD, Kamili
S, Xu F.
Dig Dis Sci. 2014 Feb 27.
Abstract
Deaths among People with Hepatitis C in New York City, 2000 - 2011.
Pinchoff J, Drobnik A, Bornschlegel K, et al
Clin Infect Dis. 2014 Feb
12
Abstract
Hepatitis C screening trends in a large integrated health system.
Linas BP, Hu H, Barter DM, Horberg M.
Am J Med. 2014 Jan 28. pii:
S0002-9343(14)00078-3
Abstract
Distinct Features in Natural History and Outcomes of Acute
Hepatitis C.
Bunchorntavakul C,
Jones LM, Kikuchi M,
et al
J Clin Gastroenterol. 2014 Jan 27
Abstract
A pharmacist-managed telemedicine clinic for hepatitis C
care: a descriptive analysis
You A, Kawamoto J, Smith JP.
J Telemed Telecare. 2014 Jan 10.
Abstract
Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results
from the NHANES 2007-2010 and HCHS/SOL Studies.
Kuniholm
MH, Jung M, Everhart JE, et al
J Infect Dis. 2014 Jan 13
Abstract
The Spectrum of Undiagnosed Hepatitis C Virus Infection in a US HIV Clinic.
Taylor
LE, Foont JA, Delong AK, et al
AIDS Patient Care STDS.
2014 Jan;28(1):4-9.
Abstract
HCV and HBV Testing Acceptability and Knowledge among Urban Emergency
Department Patients and Pharmacy Clients.
Calderon Y, Cowan E, Schramm C, et al
Prev Med.
2013 Dec 29
Abstract
During chronic HCV infection NCR dependent NK cytolytic activity directed at
HCV is associated with liver inflammation, African American Race, IL28B
genotype and response to PegIFN/RBV therapy.
Meng Q, Rani MR, Sugalski JM, et al
J Infect Dis. 2013
Dec 2.
Abstract
Hepatitis C virus: An overview for dental health care providers.
Klevens RM, Moorman AC.
J Am Dent Assoc. 2013
Dec;144(12):1340-7.
Abstract
The Changing Epidemiology of Hepatitis C Virus Infection in the United
States: National Health and Nutrition Examination Survey 2001 through 2010.
Ditah I, Ditah F, Devaki P,
et al
J Hepatol. 2013 Nov 27.
Abstract
Awareness of Biologically Confirmed HCV Among a Community
Residing Sample of Drug Users in Baltimore City.
Whitehead NE, Hearn LE, Marsiske
M, et al
J Community Health. 2013 Oct 31.
Abstract
Less-Established Risk Factors Are Common in Asian Americans with Hepatitis C
Virus: A Case-Controlled Study.
Kin KC, Lin B, Chaung KT, Ha NB, et al
Dig Dis Sci.
2013 Oct 1
Abstract
Characterization of hepatitis C infection in tuberculosis
patients in an urban city in the USA.
Campo M, Shrestha A, Oren E, Thiede H,
et al
Epidemiol Infect. 2013
Sep 25:1-8.
Abstract
Prevalence of HCV Infection Among Clients in
Community-Based Health Settings in Hawaii, 2002-2010: Assessing Risk
Factors.
Porter JC, Lusk HM, Katz
AR.
Am J Public Health. 2013
Sep 12
Abstract
Many Patients with IL28B Genotypes Associated
with Response to Therapy are Ineligible for Treatment Because of
Comorbidities.
Kanwal F, White DL, Tavakoli-Tabasi S,
et al
Clin Gastroenterol Hepatol.
2013 Aug 23.
Abstract
Hospitalizations due to hepatitis C in Los Angeles County,
2007-2009: case characteristics and factors associated with mortality.
Sie L, Gatto NM, Bancroft E.
J Viral Hepat. 2013 Sep;20(9):628-37.
Abstract
The Effect of Hepatitis C Treatment Response on Medical Costs: A
Longitudinal Analysis in an Integrated Care Setting.
Manos MM, Darbinian J, Rubin J, et al
J Manag Care Pharm. 2013
July/August;19(6):438-447
Abstract
Perceptions of drug users regarding Hepatitis C screening and
care: a qualitative study.
Jordan AE, Masson CL, Mateu-Gelabert P, et al
Harm Reduct J.
2013 Jun 20;10(1):10.
Abstract |
Main
New/Newsworthy
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
